$MXL
MAXLINEAR, INC Stock $mxl

$mxl Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000128846923000094 Filed on April 26, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$183.9M	$248.4M	$263.9M
YoY Change	-34.31%	-5.87%	26.06%
Cost Of Revenue	$81.07M	$108.1M	$109.3M
YoY Change	-29.91%	-1.1%	11.98%
Gross Profit	$102.9M	$140.3M	$154.6M
YoY Change	-37.41%	-9.24%	38.37%
Gross Profit Margin	55.93%	56.47%	58.57%
Selling, General & Admin	$33.01M	$38.65M	$40.58M
YoY Change	-25.8%	-4.74%	11.26%
% of Gross Profit	32.09%	27.55%	26.25%
Research & Development	$70.66M	$67.29M	$65.89M
YoY Change	-12.11%	2.13%	4.31%
% of Gross Profit	68.68%	47.96%	42.62%
Depreciation & Amortization	$18.71M	$19.20M	$23.88M
YoY Change	289.73%	-19.59%	6.97%
% of Gross Profit	18.18%	13.69%	15.45%
Operating Expenses	$104.4M	$113.0M	$106.5M
YoY Change	-16.73%	6.17%	4.58%
Operating Profit	-$1.501M	$27.28M	$48.13M
YoY Change	-103.85%	-43.32%	385.25%
Interest Expense	-$1.488M	$2.487M	$2.349M
YoY Change	-161.59%	5.87%	-44.15%
% of Operating Profit		9.12%	4.88%
Other Income/Expense, Net	$2.665M	-$2.178M	-$3.088M
YoY Change	-44.99%	-29.47%	-28.35%
Pretax Income	-$4.760M	$25.10M	$45.04M
YoY Change	-110.85%	-44.27%	703.12%
Income Tax	-$409.0K	$15.60M	$11.50M
% Of Pretax Income		62.15%	25.53%
Net Earnings	-$4.351M	$9.533M	$33.59M
YoY Change	-113.61%	-71.62%	783.38%
Net Earnings / Revenue	-2.37%	3.84%	12.73%
Basic Earnings Per Share	-$0.05	$0.12	$0.44
Diluted Earnings Per Share	-$0.05	$0.12	$0.42
COMMON SHARES
Basic Shares Outstanding	79.98M shares	78.75M shares	77.19M shares
Diluted Shares Outstanding	80.45M shares	81.34M shares	80.64M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$245.1M	$226.5M	$170.2M
YoY Change	4.18%	33.13%	14.9%
Cash & Equivalents	$224.6M	$207.9M	$151.1M
Short-Term Investments	$20.49M	$18.68M	$19.05M
Other Short-Term Assets	$27.44M	$28.74M	$19.68M
YoY Change	37.87%	46.02%	313.45%
Inventory	$126.2M	$149.6M	$139.0M
Prepaid Expenses
Receivables	$155.8M	$188.7M	$125.7M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$554.5M	$593.6M	$454.6M
YoY Change	2.95%	30.58%	31.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$109.0M	$77.69M	$60.02M
YoY Change	69.88%	29.44%	47.16%
Goodwill	$318.5M	$318.9M	$306.7M
YoY Change	3.82%	3.98%	1.28%
Intangibles	$91.20M	$96.35M	$140.2M
YoY Change	-28.71%	-31.25%	-26.83%
Long-Term Investments
YoY Change
Other Assets	$88.37M	$28.05M	$21.38M
YoY Change	221.87%	31.17%	183.15%
Total Long-Term Assets	$607.0M	$604.9M	$644.6M
YoY Change	-5.46%	-6.15%	-1.39%
TOTAL ASSETS
Total Short-Term Assets	$554.5M	$593.6M	$454.6M
Total Long-Term Assets	$607.0M	$604.9M	$644.6M
Total Assets	$1.161B	$1.198B	$1.099B
YoY Change	-1.63%	9.04%	10.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$45.90M	$54.58M	$60.21M
YoY Change	-37.24%	-9.36%	54.15%
Accrued Expenses	$186.4M	$112.9M	$75.55M
YoY Change	99.32%	49.49%	-2.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$241.7M	$300.2M	$234.8M
YoY Change	-23.52%	27.84%	18.8%
LONG-TERM LIABILITIES
Long-Term Debt	$122.1M	$121.9M	$286.3M
YoY Change	-50.47%	-57.42%	-16.8%
Other Long-Term Liabilities	$51.64M	$21.06M	$19.98M
YoY Change	149.14%	5.38%	46.38%
Total Long-Term Liabilities	$173.7M	$143.0M	$306.3M
YoY Change	-34.99%	-53.32%	-14.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$241.7M	$300.2M	$234.8M
Total Long-Term Liabilities	$173.7M	$143.0M	$306.3M
Total Liabilities	$415.4M	$464.4M	$571.3M
YoY Change	-32.02%	-18.71%	-1.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$40.20M	-$35.85M	-$136.8M
YoY Change	-61.67%	-73.8%	-34.4%
Common Stock	$788.5M	$771.2M	$663.6M
YoY Change	16.41%	16.21%	5.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$746.0M	$734.1M	$527.8M
YoY Change
Total Liabilities & Shareholders Equity	$1.161B	$1.198B	$1.099B
YoY Change	-1.63%	9.04%	10.07%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$4.351M	$9.533M	$33.59M
YoY Change	-113.61%	-71.62%	783.38%
Depreciation, Depletion And Amortization	$18.71M	$19.20M	$23.88M
YoY Change	289.73%	-19.59%	6.97%
Cash From Operating Activities	$30.58M	$42.16M	$134.2M
YoY Change	-75.23%	-68.58%	233.15%
INVESTING ACTIVITIES
Capital Expenditures	$12.65M	$5.216M	$4.800M
YoY Change	-212.22%	8.67%	-21.98%
Acquisitions		$9.665M	$0.00
YoY Change
Other Investing Activities	$0.00	$0.00	-$33.33M
YoY Change	-100.0%	-100.0%	566.5%
Cash From Investing Activities	-$12.65M	-$15.51M	-$42.76M
YoY Change	-22.26%	-63.73%	248.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$26.21M
YoY Change			1806.4%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	108.0K	-$6.170M	-$70.66M
YoY Change	-100.24%	-91.27%	145.2%
NET CHANGE
Cash From Operating Activities	30.58M	$42.16M	$134.2M
Cash From Investing Activities	-12.65M	-$15.51M	-$42.76M
Cash From Financing Activities	108.0K	-$6.170M	-$70.66M
Net Change In Cash	18.04M	$20.48M	$20.52M
YoY Change	-70.58%	-0.18%	-2539.36%
FREE CASH FLOW
Cash From Operating Activities	$30.58M	$42.16M	$134.2M
Capital Expenditures	$12.65M	$5.216M	$4.800M
Free Cash Flow	$17.93M	$36.94M	$129.4M
YoY Change	-86.69%	-71.44%	279.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001288469
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-34666
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	MaxLinear, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	14-1896129
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5966 La Place Court, Suite 100,
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Carlsbad
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92008
CY2023Q1	dei	City Area Code CityAreaCode	760
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	692-0711
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock
CY2023Q1	dei	Trading Symbol TradingSymbol	MXL
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	79981142	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	207850000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	187353000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	964000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	982000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	18681000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	18529000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	188733000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	170971000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	149585000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	160544000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27773000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24745000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	593586000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	563124000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	22000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	22000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	77691000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79018000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26357000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	28515000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	96352000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	109316000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	318910000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	306739000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	57515000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	66491000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	28045000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	26800000	usd
CY2023Q1	us-gaap	Assets Assets	1198478000	usd
CY2022Q4	us-gaap	Assets Assets	1180025000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	54578000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	68576000	usd
CY2023Q1	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	103797000	usd
CY2022Q4	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	113274000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	112943000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100155000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	28844000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	59081000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	300162000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	341086000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	21239000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23353000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	121910000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	121757000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	21055000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17444000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	464366000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	503640000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79981000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79981000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78745000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78745000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	8000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	8000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	771164000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	722778000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1213000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1021000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35847000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-45380000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	734112000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	676385000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1198478000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1180025000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	248442000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	263927000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	108135000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	109337000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	140307000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	154590000	usd
CY2023Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	67291000	usd
CY2022Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	65886000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38653000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	40577000	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2438000	usd
CY2022Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	4648000	usd
CY2022Q1	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	113030000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	106463000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	27277000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	48127000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	633000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	31000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	2487000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	2349000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-324000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-770000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2178000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3088000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25099000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	45039000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15566000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11453000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	9533000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	33586000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79471000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77192000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81338000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80641000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	9533000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	33586000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-71000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	2000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-192000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1075000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-192000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1075000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9341000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	32511000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	676385000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	31926000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16460000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-192000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	9533000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	734112000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	489198000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	13835000	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	26297000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18599000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1075000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	33586000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	527846000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	9533000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	33586000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19202000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23880000	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2438000	usd
CY2022Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q1	mxl	Amortization Of Debt Issuance Cost And Accretion Of Discounts AmortizationOfDebtIssuanceCostAndAccretionOfDiscounts	548000	usd
CY2022Q1	mxl	Amortization Of Debt Issuance Cost And Accretion Of Discounts AmortizationOfDebtIssuanceCostAndAccretionOfDiscounts	486000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	16448000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	18554000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	8128000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6842000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-40000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-159000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	152000	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-954000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-362000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	316000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	507000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	7120000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16931000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5969000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10959000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7338000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4338000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3503000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-886000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	32952000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	7210000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	12237000	usd
CY2023Q1	mxl	Increase Decreasein Accrued Price Protection Liability IncreaseDecreaseinAccruedPriceProtectionLiability	-9877000	usd
CY2022Q1	mxl	Increase Decreasein Accrued Price Protection Liability IncreaseDecreaseinAccruedPriceProtectionLiability	27975000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3095000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3301000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	3077000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2918000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	42159000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	134166000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5216000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4800000	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	630000	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4637000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	9665000	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023Q1	mxl	Proceeds Loaned Under Notes Receivable ProceedsLoanedUnderNotesReceivable	0	usd
CY2022Q1	mxl	Proceeds Loaned Under Notes Receivable ProceedsLoanedUnderNotesReceivable	10000000	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	23325000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15511000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42762000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	20000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	87000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6173000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	24449000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	26297000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6170000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-70659000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-230000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	20479000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	20515000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188357000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	131738000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208836000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	152253000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	2163000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	2053000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	3336000	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	1698000	usd
CY2023Q1	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	38096000	usd
CY2022Q1	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	38197000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates and Significant Risks and Uncertainties</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes of the consolidated financial statements. Actual results could differ from those estimates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of April 26, 2023, the issuance date of this Quarterly Report on Form 10-Q. Actual results could differ from those estimates.</span></div>
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	9533000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	33586000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79471000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77192000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1867000	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3449000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81338000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80641000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2200000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	900000	shares
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	4648000	usd
CY2022Q1	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	1082000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	4648000	usd
CY2023Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	2575000	usd
CY2023Q1	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	21000	usd
CY2023Q1	us-gaap	Restructuring Reserve RestructuringReserve	3176000	usd
CY2023Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	3176000	usd
CY2023Q1	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	306739000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	306668000	usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	12171000	usd
CY2022Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	usd
CY2022Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	45000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	318910000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	306713000	usd
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P6Y1M6D
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	474548000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	378196000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	96352000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	477125000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	367809000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	109316000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10387000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17024000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	109316000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	149940000	usd
CY2023Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	630000	usd
CY2022Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	4637000	usd
CY2023Q1	mxl	Finite Lived Intangible Assets Disposals FiniteLivedIntangibleAssetsDisposals	769000	usd
CY2022Q1	mxl	Finite Lived Intangible Assets Disposals FiniteLivedIntangibleAssetsDisposals	0	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10387000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17024000	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2438000	usd
CY2022Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	96352000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	137553000	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2400000	usd
CY2022Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	28272000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	23738000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	14044000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	12935000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9087000	usd
CY2023Q1	mxl	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	8276000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	96352000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	20005000	usd
CY2023Q1	mxl	Equity Securities Accumulated Net Unrealized Gain EquitySecuritiesAccumulatedNetUnrealizedGain	0	usd
CY2023Q1	mxl	Equity Securities Accumulated Net Unrealized Loss EquitySecuritiesAccumulatedNetUnrealizedLoss	1324000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	18681000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	20005000	usd
CY2022Q4	mxl	Equity Securities Accumulated Net Unrealized Gain EquitySecuritiesAccumulatedNetUnrealizedGain	0	usd
CY2022Q4	mxl	Equity Securities Accumulated Net Unrealized Loss EquitySecuritiesAccumulatedNetUnrealizedLoss	1476000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	18529000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	5253000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	18700000	usd
CY2023Q1	mxl	Equity Securities Accumulated Net Unrealized Loss EquitySecuritiesAccumulatedNetUnrealizedLoss	1300000	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	11800000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	11800000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1000000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	207850000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	187353000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	964000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	982000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	22000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	22000	usd
CY2023Q1	mxl	Cashcashequivalentsandrestrictedcash Cashcashequivalentsandrestrictedcash	208836000	usd
CY2022Q4	mxl	Cashcashequivalentsandrestrictedcash Cashcashequivalentsandrestrictedcash	188357000	usd
CY2023Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	20500000	usd
CY2022Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	400000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1000000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	88654000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	97840000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	60931000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	62704000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	149585000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	160544000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	184594000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	181101000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	106903000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	102083000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	77691000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79018000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	6400000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	4800000	usd
CY2022Q1	mxl	Proceeds Loaned Under Notes Receivable ProceedsLoanedUnderNotesReceivable	10000000	usd
CY2023Q1	mxl	Repayments Of Notes Receivable Due To The Company Annually RepaymentsOfNotesReceivableDueToTheCompanyAnnually	2000000	usd
CY2022Q4	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	113274000	usd
CY2021Q4	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	40509000	usd
CY2023Q1	mxl	Price Protection Rebate Charges PriceProtectionRebateCharges	28536000	usd
CY2022Q1	mxl	Price Protection Rebate Charges PriceProtectionRebateCharges	41473000	usd
CY2023Q1	mxl	Price Protectionpayments PriceProtectionpayments	38013000	usd
CY2022Q1	mxl	Price Protectionpayments PriceProtectionpayments	13633000	usd
CY2023Q1	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	103797000	usd
CY2022Q1	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	68349000	usd
CY2023Q1	mxl	Accrued Technology License Payments Current AccruedTechnologyLicensePaymentsCurrent	5619000	usd
CY2022Q4	mxl	Accrued Technology License Payments Current AccruedTechnologyLicensePaymentsCurrent	7402000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3451000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4072000	usd
CY2023Q1	mxl	Accrued Engineering And Production Costs AccruedEngineeringAndProductionCosts	2089000	usd
CY2022Q4	mxl	Accrued Engineering And Production Costs AccruedEngineeringAndProductionCosts	2560000	usd
CY2023Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	3176000	usd
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1082000	usd
CY2023Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1345000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1662000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10063000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10489000	usd
CY2023Q1	mxl	Accrued Customer Credits AccruedCustomerCredits	508000	usd
CY2022Q4	mxl	Accrued Customer Credits AccruedCustomerCredits	304000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	12840000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	8895000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1072000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1072000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3000000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2941000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6717000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6679000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	112943000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100155000	usd
CY2023Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-192000	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.069
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.038
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	200000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	100000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	125000000	usd
CY2023Q1	mxl	Aggregate Commitments Percentage AggregateCommitmentsPercentage	0.01
CY2023Q1	mxl	Shares Issuedupon Settlementof Executive Bonus Plan SharesIssueduponSettlementofExecutiveBonusPlan	900000	shares
CY2023Q1	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	5900000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16448000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18554000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2023Q1	mxl	Vesting Percentage Relative To Net Sales VestingPercentageRelativeToNetSales	0.60
CY2023Q1	mxl	Vesting Percentage Relative To Eps VestingPercentageRelativeToEPS	0.40
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	393000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.22
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.14
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	389000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.27
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M12D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6972000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	389000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	17.27
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y2M12D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	6972000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	389000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	17.27
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y2M12D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	6972000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	300000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	100000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	100000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	400000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15600000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11500000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	1500000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	400000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	10000.00	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	248442000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	263927000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1100000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1100000	usd
CY2023Q1	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	103800000	usd
CY2022Q4	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	113300000	usd
CY2023Q1	us-gaap	Contract With Customer Right To Recover Product ContractWithCustomerRightToRecoverProduct	300000	usd
CY2022Q4	us-gaap	Contract With Customer Right To Recover Product ContractWithCustomerRightToRecoverProduct	200000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	21239000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2900000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.034
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.034
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M24D
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	8444000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8284000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7335000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5225000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3520000	usd
CY2023Q1	mxl	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	571000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	33379000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2082000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	31302000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10063000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2500000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	200000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8000000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	100000	usd
CY2022Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	100000	usd
CY2023Q1	us-gaap	Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear	113207000	usd
CY2023Q1	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	10585000	usd
CY2023Q1	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	1968000	usd
CY2023Q1	us-gaap	Contractual Obligation ContractualObligation	125760000	usd
CY2023Q1	mxl	Research And Development Arrangement Contract For A Jointly Funded Project Cumulative Proceeds Received From Other Party Deferred In Liabilities ResearchAndDevelopmentArrangementContractForAJointlyFundedProjectCumulativeProceedsReceivedFromOtherPartyDeferredInLiabilities	9000000	usd
CY2023Q1	mxl	Research And Development Arrangement Contract For A Jointly Funded Project Cumulative Proceeds Received From Other Party Recognized ResearchAndDevelopmentArrangementContractForAJointlyFundedProjectCumulativeProceedsReceivedFromOtherPartyRecognized	0	usd
CY2022Q1	mxl	Research And Development Arrangement Contract For A Jointly Funded Project Cumulative Proceeds Received From Other Party Recognized ResearchAndDevelopmentArrangementContractForAJointlyFundedProjectCumulativeProceedsReceivedFromOtherPartyRecognized	3800000	usd
CY2023Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	usd
CY2021Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	55000000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	45000000	usd

Files In Submission

Name	View Source	Status
mxl-20230331_def.xml	Edgar Link	unprocessable
mxl-20230331_cal.xml	Edgar Link	unprocessable
0001288469-23-000094-index-headers.html	Edgar Link	pending
0001288469-23-000094-index.html	Edgar Link	pending
0001288469-23-000094.txt	Edgar Link	pending
0001288469-23-000094-xbrl.zip	Edgar Link	pending
a3312023exhibit311.htm	Edgar Link	pending
a3312023exhibit312.htm	Edgar Link	pending
a3312023exhibit321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mxl-20230331.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mxl-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
mxl-20230331_pre.xml	Edgar Link	unprocessable
mxl-20230331_lab.xml	Edgar Link	unprocessable
mxl-20230331_htm.xml	Edgar Link	completed
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MXL
MAXLINEAR, INC Stock $mxl

2023 Q2 Form 10-Q Financial Statement

#000128846923000094 Filed on April 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MXL MAXLINEAR, INC Stock $mxl

2023 Q2 Form 10-Q Financial Statement

#000128846923000094 Filed on April 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MXL
MAXLINEAR, INC Stock $mxl